Respiratory Research · 2020 · 92 citations · 13 references
MedicineImmunologyInfectious DiseasesImmunopathologyInflammationPulmonary Function TestingAcute Lung InjuryAcute Respiratory Distress SyndromeCytokine BiologyCytokine-mediated PathologyPulmonary InflammationRespiratory InfectionsAcute Lung Injury PathophysiologyCorrelation AnalysisCovid-19-associated Acute Respiratory Distress SyndromeCytokine-mediated Lung InjuryInflammatory Cytokine ProfilesPneumonia Severity AssessmentPulmonary Cytokine InflammationSars-cov-2 Pneumonia
Abstract Background Coronavirus disease 2019 (COVID-19) is a new respiratory and systemic disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The purpose of the present study was to investigate the association between cytokine profiles and lung injury in COVID-19 pneumonia. Methods This retrospective study was conducted in COVID-19 patients. Demographic characteristics, symptoms, signs, underlying diseases, and laboratory data were collected. The patients were divided into COVID-19 with pneumonia and without pneumonia. CT severity score and PaO 2 /FiO 2 ratio were used to assess lung injury. Results 106 patients with 12 COVID-19 without pneumonia and 94 COVID-19 with pneumonia were included. Compared with COVID-19 without pneumonia, COVID-19 with pneumonia had significantly higher serum interleukin (IL)-2R, IL-6, and tumor necrosis factor (TNF)-α. Correlation analysis showed that CT severity score and PaO 2 /FiO 2 were significantly correlated with age, presence of any coexisting disorder, lymphocyte count, procalcitonin, IL-2R, and IL-6. In multivariate analysis, log IL6 was the only independent explanatory variables for CT severity score (β = 0.397, p < 0.001) and PaO 2 /FiO 2 (β = − 0.434, p = 0.003). Conclusions Elevation of circulating cytokines was significantly associated with presence of pneumonia in COVID-19 and the severity of lung injury in COVID-19 pneumonia. Circulating IL-6 independently predicted the severity of lung injury in COVID-19 pneumonia.
13
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang, Yeming Wang, Xingwang Li et al. · The Lancet · 2020 · 51.8K citations · Full text
Clinical and immunological features of severe and moderate coronavirus disease 2019
Guang Chen, Di Wu, Wei Guo et al. · Journal of Clinical Investigation · 2020 · 5.1K citations · Full text
CT Imaging Features of 2019 Novel Coronavirus (2019-nCoV)
Michael Chung, Adam Bernheim, Xueyan Mei et al. · Radiology · 2020 · 2.9K citations · Full text
Effective treatment of severe COVID-19 patients with tocilizumab
Xiaoling Xu, Mingfeng Han, Tiantian Li et al. · Proceedings of the National Academy of Sciences · 2020 · 2.8K citations · Full text